Data & Security
Protectedby design
Drug-discovery data is among the most sensitive a company holds. Security, segregation and privacy are part of our architecture, not added afterwards.
- EncryptionData encrypted in transit and at rest, with managed key rotation.
- Least-privilege accessRole-based access, multi-factor authentication and quarterly reviews.
- AuditabilityAccess and processing events logged and retained for review.
Controls
How we protect data
Tenant segregation
Each partner's data and derived models are isolated from every other collaboration.
Data residency
Processing locations agreed contractually before any data is exchanged.
No cross-training
Partner data never trains models used for other parties without written consent.
Documented lineage
Every dataset carries its source, licence and consent terms.
Retention limits
Data is deleted or returned at the end of a collaboration as agreed.
Personal data minimisation
Human-derived data is de-identified and processed only where a lawful basis exists.
Standards
Working towards recognised certification
Our information-security management system is designed around the controls of ISO/IEC 27001 and the requirements of the EU General Data Protection Regulation.
Formal certification is on our roadmap; until then, we share our control documentation with partners under confidentiality.
Security questionnaire?
Our team will answer partner due-diligence requests directly.